Application

MMX

Cosmo Technologies Ltd

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88820915
Filing Date: 03/04/020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88820915
MARK INFORMATION
*MARK MMX
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT MMX
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Cosmo Technologies Ltd
*MAILING ADDRESS Riverside II, Sir John Rogerson's Quay
*CITY Dublin 2
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Ireland
*EMAIL ADDRESS n.hall@frkelly.com
LEGAL ENTITY INFORMATION
TYPE company
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY UNDER WHICH ORGANIZED Ireland
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Contrast media for use with medical equipment or in medical imaging; Diagnostic agents and reagents for medical use; Diagnostic preparations; Pharmaceutical preparations and substances; Pharmaceutical preparations for treating gastrointestinal disorders, gastrointestinal diseases or digestive system disorders; Non-prescription medicines; Gastroenteric preparations; diagnostic agents, preparations and substances for medical purposes, namely, the visual enhancing or visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions in the colon for patients undergoing endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; contrast media for medical and surgical use; contrast media for use with gastroscopic, endoscopic, colonoscopic, sigmoidoscopic, anoscopic, rectoscopic and proctoscopic equipment; pharmaceutical preparations to aid the detection, diagnosis, prevention or treatment of gastroenterological diseases; pharmaceutical preparations for use in gastroenterology, endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations containing methylene blue or dye for visual enhancing or visualization during endoscopic procedures; pharmaceutical preparations containing methylene blue or dye for pharmaceutical, medical and surgical purposes; methylene blue or dye for pharmaceutical, medical, surgical and medical diagnostic purposes; pharmaceutical preparations for the diagnosis, prevention or treatment of ulcerative colitis or inflammatory bowel diseases; pharmaceutical preparations for the treatment of fertility, reproductive health, hematology, urology, gynecology, obstetrics, endocrinology, oncology, renalology, immunology and inflammatory diseases, disorders and conditions; pharmaceutical preparations for colon and digestive system health and regulation, for improving energy levels or for maintaining and improving mucous levels and the mucosal lining of the intestines and colon; diarrhea medication; anti-nauseants; antiemetic preparations; antibiotic preparations; pharmaceutical preparations for the treatment or prevention of travellers' diarrhea, diarrhea, diverticular disease, diverticulitis or infectious colitis.
FILING BASIS SECTION 1(b)
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER 345302
       FOREIGN APPLICATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Egypt
       FOREIGN FILING DATE 11/20/2019
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS 044 
*IDENTIFICATION Providing health care information by the internet; pharmaceutical advice; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals.
FILING BASIS SECTION 1(b)
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER 18205433
       FOREIGN APPLICATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
European Union Trademark - EUTM
       FOREIGN FILING DATE 03/04/2020
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
ATTORNEY INFORMATION
NAME Joerg-Uwe Szipl
ATTORNEY DOCKET NUMBER 12343.26US01
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Merchant & Gould
STREET PO Box 2910
CITY Minneapolis
STATE Minnesota
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 55405
PHONE 612-332-5300
FAX 6123329081
EMAIL ADDRESS DOCKMPLS@merchantgould.com
DOMESTIC REPRESENTATIVE INFORMATION
NAME Joerg-Uwe Szipl
FIRM NAME Merchant & Gould
STREET PO Box 2910
CITY Minneapolis
STATE Minnesota
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP CODE 55405
PHONE 612-332-5300
FAX 6123329081
EMAIL ADDRESS DOCKMPLS@merchantgould.com
CORRESPONDENCE INFORMATION
NAME Joerg-Uwe Szipl
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE DOCKMPLS@merchantgould.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) jszipl@merchantgould.com; bburke@merchantgould.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 2
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 550
*TOTAL FEES PAID 550
SIGNATURE INFORMATION
SIGNATURE /Joerg-Uwe Szipl/
SIGNATORY'S NAME Joerg-Uwe Szipl
SIGNATORY'S POSITION Attorney of Record, VA Bar Member
SIGNATORY'S PHONE NUMBER 703-518-4502
DATE SIGNED 03/04/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88820915
Filing Date: 03/04/020

To the Commissioner for Trademarks:

MARK: MMX (Standard Characters, see mark)
The literal element of the mark consists of MMX. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Cosmo Technologies Ltd, a company organized under the laws of Ireland, having an address of
      Riverside II, Sir John Rogerson's Quay
      Dublin 2
      Ireland
      n.hall@frkelly.com

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Contrast media for use with medical equipment or in medical imaging; Diagnostic agents and reagents for medical use; Diagnostic preparations; Pharmaceutical preparations and substances; Pharmaceutical preparations for treating gastrointestinal disorders, gastrointestinal diseases or digestive system disorders; Non-prescription medicines; Gastroenteric preparations; diagnostic agents, preparations and substances for medical purposes, namely, the visual enhancing or visualization of polyps, adenomas, carcinomas, early stage cancers and other lesions in the colon for patients undergoing endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; contrast media for medical and surgical use; contrast media for use with gastroscopic, endoscopic, colonoscopic, sigmoidoscopic, anoscopic, rectoscopic and proctoscopic equipment; pharmaceutical preparations to aid the detection, diagnosis, prevention or treatment of gastroenterological diseases; pharmaceutical preparations for use in gastroenterology, endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy; pharmaceutical preparations containing methylene blue or dye for visual enhancing or visualization during endoscopic procedures; pharmaceutical preparations containing methylene blue or dye for pharmaceutical, medical and surgical purposes; methylene blue or dye for pharmaceutical, medical, surgical and medical diagnostic purposes; pharmaceutical preparations for the diagnosis, prevention or treatment of ulcerative colitis or inflammatory bowel diseases; pharmaceutical preparations for the treatment of fertility, reproductive health, hematology, urology, gynecology, obstetrics, endocrinology, oncology, renalology, immunology and inflammatory diseases, disorders and conditions; pharmaceutical preparations for colon and digestive system health and regulation, for improving energy levels or for maintaining and improving mucous levels and the mucosal lining of the intestines and colon; diarrhea medication; anti-nauseants; antiemetic preparations; antibiotic preparations; pharmaceutical preparations for the treatment or prevention of travellers' diarrhea, diarrhea, diverticular disease, diverticulitis or infectious colitis.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on Egypt application number 345302, filed 11/20/2019.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.


International Class 044:  Providing health care information by the internet; pharmaceutical advice; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on European Union Trademark - EUTM application number 18205433, filed 03/04/2020.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.




The owner's/holder's proposed attorney information: Joerg-Uwe Szipl. Joerg-Uwe Szipl of Merchant & Gould, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at
      PO Box 2910
      Minneapolis, Minnesota 55405
      United States
      612-332-5300(phone)
      6123329081(fax)
      DOCKMPLS@merchantgould.com
The docket/reference number is 12343.26US01.
Joerg-Uwe Szipl submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant hereby appoints Joerg-Uwe Szipl of Merchant & Gould
      PO Box 2910
      Minneapolis Minnesota 55405
      United States
      612-332-5300(phone)
      6123329081(fax)
      DOCKMPLS@merchantgould.com
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.

The applicant's current Correspondence Information:
      Joerg-Uwe Szipl
       PRIMARY EMAIL FOR CORRESPONDENCE: DOCKMPLS@merchantgould.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): jszipl@merchantgould.com; bburke@merchantgould.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).

Declaration

Declaration Signature

Signature: /Joerg-Uwe Szipl/   Date: 03/04/2020
Signatory's Name: Joerg-Uwe Szipl
Signatory's Position: Attorney of Record, VA Bar Member
Payment Sale Number: 88820915
Payment Accounting Date: 03/04/2020

Serial Number: 88820915
Internet Transmission Date: Wed Mar 04 15:40:13 ET 2020
TEAS Stamp: USPTO/BAS-XX.XX.XXX.X-202003041540137489
35-88820915-710a8716e489d808acdfdca8fe91
b712f5714b2115b904cd9d892f24eaf0fbc99a-C
C-40120401-20200304152349705778

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed